← Back to Investments

Kastle Therapeutics

Kastle Therapeutics is a biopharmaceutical company focused on acquiring, developing and commercializing pharmaceuticals for diseases with high unmet medical needs. Target acquisition opportunities include select therapies already approved for marketing, as well as clinical assets in late stage development.  The company is headquartered in Chicago.

Transaction Details:

Location: Chicago, IL
Investment Date: 2015
Investment Status: current